Education
About Us
Working with TipRanks
Follow Us
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
Total Valuation
Lexston Life Sciences Corp. has a market cap or net worth of C$1.41M. The enterprise value is C$1.47M.
Market CapC$1.41M
Enterprise ValueC$1.47M
Share Statistics
Lexston Life Sciences Corp. has 14,793,304 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,793,304
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lexston Life Sciences Corp.’s return on equity (ROE) is -22.88 and return on invested capital (ROIC) is -1903.91%.
Return on Equity (ROE)-22.88
Return on Assets (ROA)-5.78
Return on Invested Capital (ROIC)-1903.91%
Return on Capital Employed (ROCE)-19.04
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lexston Life Sciences Corp. is ―. Lexston Life Sciences Corp.’s PEG ratio is -0.01.
PE Ratio―
PS Ratio0.00
PB Ratio13.45
Price to Fair Value13.45
Price to FCF-0.80
Price to Operating Cash Flow-0.71
PEG Ratio-0.01
Income Statement
In the last 12 months, Lexston Life Sciences Corp. had revenue of 0.00 and earned -1.62M in profits. Earnings per share was -0.34.
Revenue0.00
Gross Profit0.00
Operating Income-1.35M
Pretax Income-1.54M
Net Income-1.62M
EBITDA-1.54M
Earnings Per Share (EPS)-0.34
Cash Flow
In the last 12 months, operating cash flow was -961.72K and capital expenditures -6.00, giving a free cash flow of -961.73K billion.
Operating Cash Flow-961.72K
Free Cash Flow-961.73K
Free Cash Flow per Share-0.07
Dividends & Yields
Lexston Life Sciences Corp. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.18
52-Week Price Change-32.89%
50-Day Moving Average0.18
200-Day Moving Average0.19
Relative Strength Index (RSI)39.49
Average Volume (3m)40.70K
Important Dates
Lexston Life Sciences Corp. upcoming earnings date is Apr 3, 2026, During Market Hours (Confirmed).
Last Earnings DateJan 14, 2026
Next Earnings DateApr 3, 2026
Ex-Dividend Date―
Financial Position
Lexston Life Sciences Corp. as a current ratio of 0.80, with Debt / Equity ratio of 0.00%
Current Ratio0.80
Quick Ratio0.80
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Lexston Life Sciences Corp. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lexston Life Sciences Corp. EV to EBITDA ratio is -0.62, with an EV/FCF ratio of -0.80.
EV to Sales0.00
EV to EBITDA-0.62
EV to Free Cash Flow-0.80
EV to Operating Cash Flow-0.80
Balance Sheet
Lexston Life Sciences Corp. has C$397.12K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$397.12K billion.
Cash & Marketable SecuritiesC$397.12K
Total DebtC$0.00
Net CashC$397.12K
Net Cash Per ShareC$0.03
Tangible Book Value Per ShareC$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lexston Life Sciences Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast28.37%